Med-Tech Convergence and Concept Validation: A New Engine Driving High-Quality Industrialization of Medical Devices

On November 21, 2024, byThe "High-Level Summit on the Integration of Medicine and Engineering: Concept Validation Boosting High-Quality Industrialization of Medical Devices – Jointly Held with the 2024 Annual Meeting of the Medical-Engineering Translation Professional Committee of the Jiangsu Society of Biomedical Engineering and the 2024 Annual Meeting of the China University of Mining and Technology Medical Alumni Association," hosted by Jiangsu Dongmai Medical Technology Group Co., Ltd., the Medical-Engineering Translation Professional Committee of the Jiangsu Society of Biomedical Engineering, and the China University of Mining and Technology Medical Alumni Association, and co-organized by Lianyungang Dongmai Medical Technology Co., Ltd.Concluded successfully in Lianyungang.

The conference is organized byDeputy Secretary-General of the China Association for Medical Devices Industry, Zhang LinServed as the host to announce the opening of the ceremony. This conference brings together high-quality industry service platforms, research institutions, representatives from industry funds, and experts and scholars, aiming to conduct in-depth discussions onProof of Concepta pivotal role in accelerating the innovation and commercialization of medical devices. Meanwhile, the forum will also focus on the development of Lianyungang’s medical device industry, promoting its transformation, upgrading, and high-quality growth through exchange and collaboration.

Zhang Lin, Deputy Secretary-General of the China Association for Medical Device Industry

Coinciding with the fifth anniversary of Dongmai Medical Group (hereinafter referred to as the “Group”), the opening ceremony of the Group’s CDMO base in Lianyungang was successfully held, with plans for official operation in December.Tian Yahui, Member of the Party Working Committee and Deputy Director of the Administrative Committee of Lianyungang High-Tech Industrial Development Zone,Chen Tao, Chairman of Dongmai Medical Group, along with the group’s deep strategic partners, attended the event and jointly participated in the ribbon-cutting ceremony for the base’s opening.

*From left to right:

Ge Jianjun, Qian Zhiyu, Zhang Lin, Chen Tao, Wu Xiaodong, Zhao Qiang, Li Xia, Gu Xiaochun

Joint Ribbon-Cutting Ceremony for the Opening of VCBeat’s Lianyungang Base

Qian Zhiyu, Chairman of the Jiangsu Society for Biomedical Engineering, stated, “Domestically developed new technologies have entered a period of rapid development. In the process of innovation and commercialization, new products and technologies must leverage platform capabilities to penetrate high-end markets. The operation and resource advantages of the Dongmai Lianyungang Base provide an excellent industrial environment for the integration of medicine and engineering.”

▼

Qian Zhiyu, Chairman of the Jiangsu Society for Biomedical Engineering

Li Xia, Deputy Director of the Office of External Cooperation and Development at China University of Mining and Technology, shared, “Alumni from China University of Mining and Technology working in the medical field have become a core force in areas such as medical imaging, integration of medicine and engineering, and medical devices. In the future, the alumni association needs to continuously stimulate alumni engagement, anchor its impact, clarify directions, and integrate resources. We believe that by leveraging the platform advantages of Dongmai Medical, we can maximize this collective strength.”

Li Xia, Deputy Director of the Office of External Cooperation and Development, China University of Mining and Technology

Chen Tao, Chairman of Dongmai Medical Group, delivered a speech at the conference: As a member of the industry, Dongmai Medical has always adhered to the philosophy of “serving as the aorta for innovation and entrepreneurship in medical devices,” acting as a diligent ferryman. In recent years, we have successfully obtained approval for the Suzhou Medical Device Med-Engineering Cross-Disciplinary Concept Verification Center and taken the lead in establishing the Professional Committee on Med-Engineering Translation, both dedicated to promoting innovation and breakthroughs in medical device technology. Moving forward, we will seize industrial development opportunities at various stages, uphold the core principle of “compliance,” and focus on key business modules such as localization of imported devices, translation of med-engineering projects, and intensification of existing enterprises. Together with our partners, we have built an ecosystem for medical device industry services, achieving the industrialization goal of “Give us a prototype, and we will return a mass-producible product with registration certification.” We extend our gratitude to the Administrative Committee of Lianyungang High-Tech Industrial Development Zone and relevant departments for their support and assistance. Next, with the opening of our Lianyungang base as a new starting point, the Group will join hands with Lianyungang to adhere to “innovation-led development,” striving to “blossom health and bear the fruits of life” in Lianyungang. We aim to drive regional industrial innovation through corporate technological innovation, thereby boosting the high-quality development of Lianyungang’s biopharmaceutical industry.

Chen Tao, Chairman of Dongmai Medical Group

At the conference, Professor Zhao Qiang, Vice President of the Jiangsu Health Information Society and founding dean of the former School of Medical Informatics at Xuzhou Medical University,"The Impact and Influence of the Surge in Artificial Intelligence on Clinical Medicine"Share insights on the applications and challenges of artificial intelligence in clinical settings. Drawing upon real-world medical cases and operational experience, engage with guests to jointly explore effective pathways and solutions for integrating AI into the healthcare industry, its anticipated social benefits, and directions for technological innovation.

Zhao Qiang, Vice President of the Jiangsu Provincial Health Information Society / Founding Dean and Professor of the former School of Medical Informatics at Xuzhou Medical University

From an industry perspective, Xu Gaojian, Vice President of Business at Dongmai Medical Group, shared insights on the trends in medical device enterprises and the challenges facing the industry at the conference. Mr. Xu stated that to align with market development, Dongmai’s CDMO+CRO platform has evolved from a service provider into an ecosystem collaboration carrier, pooling industry strengths to achieve symbiotic growth, mutual benefit, and high-quality development.“As long as entrepreneurs stay in the game, infinite possibilities remain. Our mission at Dongmai, as a CDMO+CRO platform, is to empower our partners to play their hands well and win.”

Xu Gaojian, Deputy Vice President of Business at Dongmai Medical Group

“The establishment of a Proof-of-Concept Center platform can integrate research institutes and other entities across the industrial chain during the translation process of medical devices, while fostering appropriate and in-depth collaboration with hospitals to jointly achieve an effective closed loop from R&D to commercialization for domestically produced medical devices,” shared Li Zhiyang, Head of the Department of Translational Medicine at Nanjing Drum Tower Hospital, at the conference.Construction Experience of the Jiangsu Province Concept Verification Center (Nanjing Drum Tower Hospital)

Li Zhiyang, Head of the Department of Translational Medicine, Nanjing Drum Tower Hospital

At this high-level summit, Dongmai Medical andCMO Clients, Nanjing Institute of Translational Medicine, and Kaais Jointly Establish the Advanced Medical Energy Systems (Lianyungang) Technology Research InstituteA signing ceremony was held on-site, a move of significant importance.

Through its contractual collaborations with various partners, Dongmai Medical will fully leverage their respective strengths to engage in extensive cooperation across multiple areas, including project industrialization, resource integration, medical-engineering translation, and academic promotion. This will inject new momentum into Lianyungang High-Tech Zone’s efforts to build a key growth pole for new quality productive forces.

Dongmai Medical & Client CMO Cooperation Signing

Dongmai Medical & Nanjing Institute of Translational Medicine Sign Cooperation Agreement

Dongmai Medical & Kaaisi Jointly Establish Advanced Medical Energy Systems (Lianyungang) Technical Research Institute Cooperation Signing Ceremony

At this high-level summit, the spotlight was onSleep Regulation Device, Medical Surgical Instruments, Plasma Therapy, Radiofrequency Beauty Device, Medical Large Language ModelFive scientific research projects. Guest speakers, representing the major trends of medical-engineering integration in medical devices and domestic substitution, combined with Dongmai Medical’s provision ofSupporting Advantages of CDMO Services, providing a detailed introduction and sharing insightful perspectives on their innovation and entrepreneurship projects from multiple angles, including market prospects, business model, core products, management team, financial revenue, financing plans, and future project planning.

At the roundtable forum, centered on “Cross-Border Integration · Co-Creating the Future: A Multi-Stakeholder Dialogue on Innovation and Commercialization of Medical Devices“Theme: Drawing on their own research experiences and corporate development trajectories, the experts engaged in an in-depth discussion on the integration and application of key elements driving technological innovation, collaborative translation, market traffic, medical-engineering interdisciplinary convergence, and concept verification centers.”

From left to right: Chen Tao, Ge Jianjun, Hu Peng, Hong Di, Miao Song

With the joint efforts of all our partners, thisMedical-Engineering Integration • Concept Verification Boosts High-Quality Industrialization of Medical Devices: Summit Forumachieved complete success.

This forum brought together leading experts and elites for high-quality, high-level, and open disciplinary exchanges. Participants jointly explored the “expansion” of the industrial chain, shared new approaches and models for the deep integration and convergence of technologies in niche sectors with industrial development, and empowered a complementary ecosystem of industrial innovation and high-quality development across the upstream, midstream, and downstream segments of the medical device supply chain. Together, they delivered an extraordinary academic event that is expected to provide fresh industry insights for entrepreneurs, hospitals, investors, and research institutions. Dongmai Medical will remain true to its original aspiration and keep its mission firmly in mind, working hand in hand with enterprises across the board to drive the robust growth of the medical device industry!